An engine for progress

Dennis Murphy is President and Chief Executive Officer of IU Health. With over 38,000 employees, 16 hospitals, and more than 300 clinical sites, IU Health is the largest integrated healthcare system in Indiana and one of the largest in the country.

Dennis joined IU Health in 2013 as Chief Operating Officer and was named CEO in 2016. Under his leadership, IU Health has launched high-quality destination health programs, created community health initiatives to combat underlying impediments to health, and executed a care affordability strategy to control the cost of care.

Dennis has spent his career at academic health centers, with previous leadership positions at Northwestern Medicine, University of Chicago Medicine, and Johns Hopkins Hospital. A Chicago native, he holds a B.A. from the University of Notre Dame and M.H.A. from Duke University.

Dennis and his wife Kristy have three children and live in Carmel, Indiana.

Alan Palkowitz has served as IBRI’s President and CEO since September 2020. Leveraging his more than 30 years of experience in drug discovery and development in both industry and academia, Dr. Palkowitz leads the organization’s full spectrum of activities to catalyze translational research progress across the life sciences ecosystem.

In addition to his role at the IBRI, Dr. Palkowitz maintains his appointment at the Indiana University (IU) School of Medicine as a research professor of medicine. In this role, he directs the NIH-NIA-sponsored TREAT-AD Center, which focuses on the discovery of novel therapies for Alzheimer’s disease.

Dr. Palkowitz began his career in research at Eli Lilly and Company, holding roles of increasing responsibility culminating in his position as Vice President of Discovery Chemistry Research and Technologies. In this capacity, he was a key member of the Lilly research leadership team responsible for the global small molecule drug discovery strategy and the delivery of clinical candidates in disease areas including cancer, diabetes, immunology, pain, and neurodegenerative disorders.

Dr. Palkowitz has served on several prominent advisory committees, including the National Institutes of Health’s National Center for Advancing Translational Sciences Advisory Council and the National Academies of Sciences’ Board on Chemical Sciences and Technology. He has published numerous research articles and is an inventor on 60 U.S. patents. Dr. Palkowitz obtained his Ph.D. in synthetic organic chemistry from the Massachusetts Institute of Technology and his bachelor’s degree in chemistry from the University of California at Berkeley.